Clinical Trials Browser

Neoplasms × Dexamethasone × 90 days × Clear all

NCT01946477 2026-05-22

POM MM 014

Phase 2 Completed

186 enrolled 17 charts

Multiple Myeloma, Neoplasms, Plasmacytoma

NCT05099471 2026-05-05

VIWA-1

Phase 2 Recruiting

Lymphoma, Waldenstrom Macroglobulinemia, Neoplasms

NCT02626481 2026-04-07

IFM2014-04

Phase 2 Completed

Multiple Myeloma, Neoplasms

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Phase 2/3 Active not recruiting

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT04300556 2026-03-13

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Phase 1/2 Recruiting

BreastGynecologicThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05789589 2026-03-04

ADORATION

Phase 1/2 Recruiting

Brain Neoplasms, Neoplasm Metastasis, Neoplasms